180 related articles for article (PubMed ID: 35068790)
21. Simultaneous splenectomy improves outcomes after adult living donor liver transplantation.
Yoshizumi T; Itoh S; Shimokawa M; Inokuchi S; Harada N; Takeishi K; Mano Y; Yoshiya S; Kurihara T; Nagao Y; Ikegami T; Soejima Y; Mori M
J Hepatol; 2021 Feb; 74(2):372-379. PubMed ID: 32827564
[TBL] [Abstract][Full Text] [Related]
22. Graft Inflow Modulation by Splenic Artery Ligation for Portal Hyper Perfusion does not Decrease Rates of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: A Randomized Control Trial.
Pamecha V; Tharun G; Patil N; Mohapatra N; Kumar A; Thapar S; Sindwani G; Dhingra U; Yadav A
Ann Surg; 2024 Jun; ():. PubMed ID: 38841843
[TBL] [Abstract][Full Text] [Related]
23. Donor information based prediction of early allograft dysfunction and outcome in liver transplantation.
Hoyer DP; Paul A; Gallinat A; Molmenti EP; Reinhardt R; Minor T; Saner FH; Canbay A; Treckmann JW; Sotiropoulos GC; Mathé Z
Liver Int; 2015 Jan; 35(1):156-63. PubMed ID: 24351095
[TBL] [Abstract][Full Text] [Related]
24. A pilot study of ex-vivo MRI-PDFF of donor livers for assessment of steatosis and predicting early graft dysfunction.
Satapathy SK; Gonzalez HC; Vanatta J; Dyer A; Angel W; Nouer SS; Kocak M; Kedia SK; Jiang Y; Clark I; Yadak N; Nezakagtoo N; Helmick R; Horton P; Campos L; Agbim U; Maliakkal B; Maluf D; Nair S; Halford HH; Eason JD
PLoS One; 2020; 15(5):e0232006. PubMed ID: 32407331
[TBL] [Abstract][Full Text] [Related]
25. Influence of intraoperative oxygen content on early postoperative graft dysfunction in living donor liver transplantation: A STROBE-compliant retrospective observational study.
Lee HM; Kim T; Choi HJ; Park J; Shim JW; Kim YS; Moon YE; Hong SH; Chae MS
Medicine (Baltimore); 2020 May; 99(21):e20339. PubMed ID: 32481323
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.
Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831
[TBL] [Abstract][Full Text] [Related]
27. von Willebrand factor to protein C ratio-related thrombogenicity with systemic inflammation is predictive of graft dysfunction after liver transplantation: Retrospective cohort study.
Kwon HM; Kim KS; Park J; Jeong J; Moon YJ; Song JG; Hwang GS; Kim KH; Jun IG
Int J Surg; 2020 Dec; 84():109-116. PubMed ID: 33137460
[TBL] [Abstract][Full Text] [Related]
28. Prediction model for early graft failure after liver transplantation using aspartate aminotransferase, total bilirubin and coagulation factor.
Rhu J; Kim JM; Kim K; Yoo H; Choi GS; Joh JW
Sci Rep; 2021 Jun; 11(1):12909. PubMed ID: 34145352
[TBL] [Abstract][Full Text] [Related]
29. Role of intelligent/interactive qualitative and quantitative analysis-three-dimensional estimated model in donor-recipient size mismatch following deceased donor liver transplantation.
Ding H; Ding ZG; Xiao WJ; Mao XN; Wang Q; Zhang YC; Cai H; Gong W
World J Gastroenterol; 2023 Nov; 29(44):5894-5906. PubMed ID: 38111507
[TBL] [Abstract][Full Text] [Related]
30. A panel of biomarkers in the prediction for early allograft dysfunction and mortality after living donor liver transplantation.
Tsai HI; Lo CJ; Lee CW; Lin JR; Lee WC; Ho HY; Tsai CY; Cheng ML; Yu HP
Am J Transl Res; 2021; 13(1):372-382. PubMed ID: 33527031
[TBL] [Abstract][Full Text] [Related]
31. Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements.
Lee DD; Croome KP; Shalev JA; Musto KR; Sharma M; Keaveny AP; Taner CB
Ann Hepatol; 2016; 15(1):53-60. PubMed ID: 26626641
[TBL] [Abstract][Full Text] [Related]
32. Do Natural Portosystemic Shunts Need to Be Compulsorily Ligated in Living Donor Liver Transplantation?
Vijayashanker A; Chikkala BR; Ghimire R; Nidoni R; Acharya MR; Pandey Y; Dey R; Kaloo SB; Agarwal S; Gupta S
J Clin Exp Hepatol; 2022; 12(1):29-36. PubMed ID: 35068782
[TBL] [Abstract][Full Text] [Related]
33. Prediction of early allograft dysfunction using serum phosphorus level in living donor liver transplantation.
Hong SH; Kwak JA; Chon JY; Park CS
Transpl Int; 2013 Apr; 26(4):402-10. PubMed ID: 23350888
[TBL] [Abstract][Full Text] [Related]
34. A Lipidomics Study Reveals Lipid Signatures Associated with Early Allograft Dysfunction in Living Donor Liver Transplantation.
Tsai HI; Lo CJ; Zheng CW; Lee CW; Lee WC; Lin JR; Shiao MS; Cheng ML; Yu HP
J Clin Med; 2018 Dec; 8(1):. PubMed ID: 30597989
[TBL] [Abstract][Full Text] [Related]
35. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
[TBL] [Abstract][Full Text] [Related]
36. Analysis of failure in living donor liver transplantation: differential outcomes in children and adults.
Goldstein MJ; Salame E; Kapur S; Kinkhabwala M; LaPointe-Rudow D; Harren N P P; Lobritto SJ; Russo M; Brown RS; Cataldegirmen G; Weinberg A; Renz JF; Emond JC
World J Surg; 2003 Mar; 27(3):356-64. PubMed ID: 12607066
[TBL] [Abstract][Full Text] [Related]
37. Uric Acid as a Predictor for Early Allograft Dysfunction after Living Donor Liver Transplantation: A Prospective Observational Study.
Hu LM; Tsai HI; Lee CW; Chen HM; Lee WC; Yu HP
J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34205627
[TBL] [Abstract][Full Text] [Related]
38. A score model for the continuous grading of early allograft dysfunction severity.
Pareja E; Cortes M; Hervás D; Mir J; Valdivieso A; Castell JV; Lahoz A
Liver Transpl; 2015 Jan; 21(1):38-46. PubMed ID: 25204890
[TBL] [Abstract][Full Text] [Related]
39. Left lobe living donor liver transplantation in adults: What is the safety limit?
Ikegami T; Yoshizumi T; Sakata K; Uchiyama H; Harimoto N; Harada N; Itoh S; Nagatsu A; Soejima Y; Maehara Y
Liver Transpl; 2016 Dec; 22(12):1666-1675. PubMed ID: 27540888
[TBL] [Abstract][Full Text] [Related]
40. Secondary non-resectable liver tumors: A single-center living-donor and deceased-donor liver transplantation case series.
Lerut J; Iesari S; Vandeplas G; Fabbrizio T; Ackenine K; Núñez MEI; Komuta M; Coubeau L; Ciccarelli O; Bonaccorsi-Riani E
Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):412-422. PubMed ID: 31521538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
